文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

针对肝细胞癌中的铁死亡

Targeting ferroptosis in hepatocellular carcinoma.

作者信息

Mo Yuqian, Zou Zhilin, Chen Erbao

机构信息

School of Public Health, Guangdong Medical University, Zhanjiang, Guangdong, China.

Department of Ophthalmology, Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

Hepatol Int. 2024 Feb;18(1):32-49. doi: 10.1007/s12072-023-10593-y. Epub 2023 Oct 26.


DOI:10.1007/s12072-023-10593-y
PMID:37880567
Abstract

Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.

摘要

肝细胞癌(HCC)是一种常见的恶性肿瘤,其生存机制复杂且具有耐药性,导致全球癌症相关死亡率居高不下。铁死亡是一种程序性细胞死亡形式,其典型特征是铁依赖性脂质过氧化。癌细胞常利用抗氧化防御机制来规避过量铁的有害影响。最近的研究表明,针对铁死亡进行干预可能是抑制HCC增殖和侵袭的有效策略。免疫疗法在重塑免疫微环境方面取得了一些初步进展,但尚未完全抑制HCC的生长、侵袭和耐药性。此外,铁死亡在HCC免疫微环境的形成中广泛存在,并介导许多靶向药物和免疫疗法的反应。阐明铁死亡在这些复杂过程中的作用有望为HCC治疗提供新的前景。在这篇综述中,我们概述了HCC通过逃避铁依赖性死亡而产生侵袭性和耐药性的机制,并描绘了HCC免疫微环境中不同细胞类型中铁死亡的全面图景。

相似文献

[1]
Targeting ferroptosis in hepatocellular carcinoma.

Hepatol Int. 2024-2

[2]
Ferroptosis: a new promising target for hepatocellular carcinoma therapy.

Mol Cell Biochem. 2024-10

[3]
A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.

Front Immunol. 2022

[4]
Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.

Cell Mol Gastroenterol Hepatol. 2023

[5]
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.

Cell Commun Signal. 2020-10-28

[6]
Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.

Phytomedicine. 2024-1

[7]
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.

Cancer Lett. 2024-7-1

[8]
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.

Br J Cancer. 2023-1

[9]
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.

J Exp Clin Cancer Res. 2022-1-3

[10]
Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).

Int J Oncol. 2024-6

引用本文的文献

[1]
Inhibition of dipeptidyl peptidase 9 improves sorafenib sensitivity by inducing ferroptosis in hepatocellular carcinoma.

J Cancer Res Clin Oncol. 2025-9-9

[2]
CD44 Receptor-Mediated Ferroptosis Induction by Hyaluronic Acid Carbon Quantum Dots in Triple-Negative Breast Cancer Cells Through Downregulation of SLC7A11 Pathway.

Materials (Basel). 2025-5-6

[3]
Cellular Membrane Protein GRINA is Highly Expressed and Associated with Survival Outcomes in Liver Cancer Patients.

Curr Med Sci. 2025-2

[4]
Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma.

Transl Cancer Res. 2025-1-31

[5]
CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96.

J Mol Med (Berl). 2025-3

[6]
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer.

J Transl Med. 2024-12-22

[7]
Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis.

Front Immunol. 2024

[8]
Multifaceted bioinformatic analysis of m6A-related ferroptosis and its link with gene signatures and tumour-infiltrating immune cells in gliomas.

J Cell Mol Med. 2024-9

[9]
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma.

Int J Biol Sci. 2024

[10]
Identification of SLC7A11-AS1/SLC7A11 pair as a ferroptosis-related therapeutic target for hepatocellular carcinoma.

J Cell Mol Med. 2024-7

本文引用的文献

[1]
The antioxidant glutathione.

Vitam Horm. 2023

[2]
Ferroptosis of tumour neutrophils causes immune suppression in cancer.

Nature. 2022-12

[3]
Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.

Cancer Cell Int. 2022-10-13

[4]
Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.

JAMA Surg. 2022-12-1

[5]
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma.

Acta Pharmacol Sin. 2023-3

[6]
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.

Redox Biol. 2022-10

[7]
SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.

Cell Death Differ. 2023-1

[8]
Screening of ferroptosis-related genes in sepsis-induced liver failure and analysis of immune correlation.

PeerJ. 2022

[9]
Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma.

Cancer Gene Ther. 2022-12

[10]
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.

Cancer Res. 2022-9-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索